Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
EyeROV (IROV TECHNOLOGIES PRIVATE LIMITED)
India
- ERNAKULAM, KERALA
- 13/08/2024
- Pre Series A
- $1,190,974
EyeROV (IROV Technologies Pvt. Ltd.) vision is to be the technology leader and solution provider in underwater critical infrastructure inspections and surveys. EyeROV, our first product - a smart and efficient micro-ROV(Remotely Operated Vehicle)/underwater drone is our first step towards this vision.
The company is founded by IIT Alumnus Johns T Mathai and Kannappa Palaniappan P. Johns did his Master from IIT Delhi in Electrical Engineering(2013) and Kannappa Palaniappan P in Ocean Engineering from IIT Madras(2014). Johns then worked in Samsung R&D Bangalore and Grey Orange Robotics. Kannappa has Industrial experience working in Saint Gobain and National Institute of Ocean Technology (NIOT). The company also has reputed advisors from ex-DRDO, ex-Navy and Marine Industry. The company is now incubated at Maker Village an initiative of Govt of India and Govt of Kerala.
- Industry Maritime Transportation
- Website https://www.eyerov.com/
- LinkedIn https://www.linkedin.com/company/eyerov/
Related People
Johns T MathaiFounder
India -
Ernakulam, Kerala
I am an entrepreneur passionate about
- Robotics
- Entrepreneurship
- Building Hardware
I have built along with Kannappa, EyeROV a marine robotics startup.
Alumnus of IIT Delhi and College Of Engineering (CET), Trivandrum with specialization in Electronics and Electrical Engineering.
Previously worked with Samsung R&D and Grey Orange Robotics.
AnswersNow | $40,000,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)